News Releases

Q2 revenue of $2.88 billion , up 0.5% from $2.87 billion last year; excluding the disposition of businesses revenue grew 2.4% Q2 diluted EPS of $1.93 , down 15% from $2.27 last year; Q2 adjusted EPS of $2.93 , down 2% from $2.98 last year 2019 adjusted EPS guidance of $11.10 to $11.40 , up 1% to 3%

Pixel by LabCorp Now Available with Phlebotomy Collection Through LabCorp’s Nationwide Patient Service Center Network BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 22, 2019-- LabCorp® (NYSE: LH), a leading global life sciences company, today announced a significant expansion to its Pixel by LabCorp™

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 1, 2019-- LabCorp® (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 25, 2019-- LabCorp® (NYSE: LH) will release its second quarter of 2019 financial results before the market opens on Thursday, July 25, 2019 , followed by a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

Philips IntelliSite Pathology Solution will be deployed across the Mount Sinai Health System to support greater efficiency and help improve patient care BURLINGTON, N.C. & NEW YORK & AMSTERDAM--(BUSINESS WIRE)--Jun. 18, 2019-- LabCorp® (NYSE: LH) and the Mount Sinai Health System today announced

David P. King , current chairman, president and CEO of LabCorp, to become executive chairman of the board of directors effective Nov. 1 , retiring Oct. 31 as president and CEO Adam H. Schechter , current lead independent director of LabCorp and longtime Merck executive, to become president and CEO

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 3, 2019-- On June 3, 2019 , LabCorp® (NYSE: LH) entered into a new Term Loan Credit Agreement, which provides for a two-year term loan credit facility in the principal amount of $850 million (the “New Term Loan Facility”). Bank of America, N.A.

LabCorp Acquires Envigo’s Global Nonclinical Contract Research Business, Envigo Acquires LabCorp’s Covance Research Products Business BURLINGTON, N.C. & INDIANAPOLIS --(BUSINESS WIRE)--Jun. 3, 2019-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding

New Test Further Underscores LabCorp’s Leadership in Development and Commercialization of Innovative Lab Testing BURLINGTON, N.C. --(BUSINESS WIRE)--May 10, 2019-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced the

BURLINGTON, N.C. --(BUSINESS WIRE)--May 2, 2019-- LabCorp® (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 9, 2019 , at 9:00 a.m. Eastern Daylight Time via the Company website at www.LabCorp.com . An archived replay of the audio webcast will be

Q1 revenue of $2.79 billion , down 2% from $2.85 billion last year Q1 diluted EPS of $1.86 , up 11% from $1.67 last year; Q1 adjusted EPS of $2.62 , down 6% from $2.78 last year 2019 adjusted EPS guidance increased to $11.05 to $11.45 , from $11.00 to $11.40 2019 free cash flow guidance of $950

LabCorp will purchase Envigo’s nonclinical contract research services business, expanding the global reach and capabilities of Covance’s nonclinical drug development business Envigo’s research models and services business will purchase Covance’s research products business located in the United

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 1, 2019-- LabCorp® (NYSE: LH) will release its first quarter of 2019 financial results before the market opens on Tuesday, April 30, 2019 , followed by a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 1, 2019-- LabCorp® (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject

Receives Designation as a Best Place to Work for LGBTQ Equality for Second Year in a Row BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 28, 2019-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it received a perfect

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 11, 2019-- LabCorp® (NYSE: LH) announced today that for the period of March 11, 2019 to Sept. 10, 2019 , its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will accrue (subject to the terms of the Zero Coupon Notes) contingent cash

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 5, 2019-- LabCorp® (NYSE: LH) today announced it will participate at the 2019 Barclays Global Healthcare Conference . LabCorp’s presentation is planned for Tuesday, March 12, 2019 , at 8:30 a.m. (ET) . A live audio webcast of the presentation will be

Revenue: Q4 of $2.8 billion , up 2% over 2017; Full year of $11.3 billion , up 10% over 2017 Diluted EPS: Q4 of $1.56 ; Full year of $8.61 Adjusted EPS: Q4 of $2.52 , up 11% over 2017; Full year of $11.02 , up 20% over 2017 2019 Adjusted EPS guidance of $11.00 to $11.40 2019 Free Cash Flow guidance

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 22, 2019-- LabCorp® (NYSE: LH), a leading global life sciences company, today announced that it has been named to  FORTUNE  magazine's 2019 List of World’s Most Admired Companies, making the annual list for the second consecutive year.

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 16, 2019-- LabCorp® (NYSE: LH) will release its fourth quarter and full year 2018 financial results before the market opens on Thursday, Feb. 7, 2019 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

LabCorp Will Provide Enhanced Laboratory Services, With an Emphasis on Chronic Diseases, for Clinics Serving More Than One Million Patients Annually BURLINGTON, N.C. & AUSTIN, Texas --(BUSINESS WIRE)--Jan. 15, 2019-- LabCorp® (NYSE: LH) a leading global life sciences company, and the Texas

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 3, 2019-- LabCorp® (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject

Multi-Biomarker Test Will Provide the Clinical Research Community with a Non-Invasive Tool to Identify and Monitor Patients with NASH and Significant Fibrosis LILLE, France & CAMBRIDGE, Mass. & BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 3, 2019-- LabCorp® (NYSE: LH), a leading global life sciences